Entering text into the input field will update the search result below

GlycoMimetics, Inc. (GLYC) CEO Rachel King on Q1 2020 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

GlycoMimetics, Inc. (NASDAQ:GLYC) Q1 2020 Earnings Conference Call May 1, 2020 8:30 AM ET

Company Participants

Shari Annes - Investor Relations

Rachel King - Chief Executive Officer

Brian Hahn - Senior Vice President and Chief Financial Officer

Helen Thackray - Senior Vice President, Development and Chief Medical Officer

Conference Call Participants

Ed White - HC Wainwright

Boris Peaker - Cowen

Stephen Willey - Stifel

Zegbeh Jallah - ROTH Capital Partners

Biren Amin - Jefferies


Good morning and thank you for joining the GlycoMimetics Corporate Update Conference Call. [Operator Instructions] I would now like to turn the call over to Ms. Shari Annes of Investor Relations Group of GlycoMimetics. Please go ahead.

Shari Annes

Good morning. Today, we will review our accomplishments and financial results for the first quarter of 2020. The press release we issued this morning is available on the company’s website at www.glycomimetics.com under the Investors tab. This call is being recorded. A dial-in phone replay will be available for 24 hours after the close of the call. The webcast replay will also be available in the Investor Relations section of the company’s website for 30 days.

Joining me on the call today from GlycoMimetics are Rachel King, Chief Executive Officer; Brian Hahn, Senior VP and Chief Financial Officer; and Dr. Helen Thackray, our Senior VP of Development and Chief Medical Officer. We will start today’s call with comments from Rachel and Helen, and after that, Brian will provide an overview of the company’s financial position. We will then open the call for Q&A.

I would like to remind you that today’s call will include forward-looking statements based on current expectations. Forward-looking statements contained on this call include, but are not limited to, statements about the company’s product candidates, uproleselan, GMI-1359 and rivipansel as well as our other pipeline programs and the

Recommended For You

Comments (1)

I agree
To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.